Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
2019
Abstract Background Niraparib, an inhibitor of poly(adenosine diphosphate [ADP]–ribose) polymerase (PARP), has been associated with significantly increased progression-free survival among patients ...
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
15
References
484
Citations
NaN
KQI